A recent study shows 9% of cholecystectomy procedures are performed robotically and offer better outcomes when compared to laparoscopy I thought the reference to Dr Maegawa’s study comparing robotic with laparoscopic cholecystectomy was very interesting in the Intuitive call. This is a cohort of 59,216 patients from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) for 2022. 5,470 of these were done robotically, The conclusion was that robotic cholecystectomy was independently associated with a lower risk of serious complications, lower rate conversion to open, and hospitalization ≥24 hours compared with laparoscopic cholecystectomy. However the rate of readmission and reoperation were not significantly different. This is very interesting as Cholecystecomies has been one of the areas where there has been the greatest push back to robotics being used due to perceived cost and lack of evidence on benefits. There are between 700,000 and 750,000 Choly procedures performed in the US every year. I would be surprised if 60,000 have been done robotically nationally. The big question is are these three improvements big enough to justify the cost variable. This I believe will be good news for the Versius team as CMR Surgical has just received their FDA approval for use with Cholecystectomies. Will they be able to show equivalent benefits at a lower price point to Da Vinci that could make their offering attractive.
Roy Chin
1mo
Christopher Simmonds This is indeed a good publications comparing manual versus robotic cholecystectomy. The low percentage of general surgeons using the robot explains to why Stryker Endoscopy kept emphasizing that DaVinci hasn’t yet affected its endoscopic top line. Now that this is article is released, and Stryker’s offensive move would trigger the company to get into soft tissue robot sooner than later.
Merci Chris pour les informations et l’article !😊😊😊
These findings a completely comparable with our results!